课题基金 / 基金详情

A Novel Strategy for Active Control of DNA Recognition by External Stimulates -Peptide Ribonucleic Acids (PRNA)-

A Novel Strategy for Active Control of DNA Recognition by External Stimulates -Peptide Ribonucleic Acids (PRNA)-
通过外部刺激主动控制 DNA 识别的新策略 - 肽核糖核酸 (PRNA)-
批准号:
13132206
负责人:
WADA Takehiko
金额:
$27.33万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2004

项目摘要

项目成果

WADA Takehiko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In the development of nucleic acid models for the next generation of functional materials, if the recognition control and/or reversible recognition control of nucleic acids by a novel nucleic acid model could be achieved, the dynamic expression/suppression of functions as to external stimulates and/or factor could be materialized. Thus, the subject of this work was dynamic and reversible control of nucleic acid recognition by an external factor and/or stimulate, which cannot be realized by the conventional nucleic acid model compounds based on a structure of nucleic acids. In this work, focusing on the importance of reversible DNA recognition dependent, the author found the novel strategy for reversible DNA recognition control by change of pH system with peptide ribonucleic acids (PRNAs). The author established the synthetic routes to a series of PRNA monomers, carrying adenine, cytosine, hypoxanthine, and uracil nucleobases as recognition sites. This enabled us to fully expand the ran … More ge of available PRNA monomers. The author further demonstrated that the newly synthesized Fmoc-protected PRNA monomers are compatible with the standard solid-phase peptide synthesis protocol, and oligomeric PRNAs with purine-pyrimidine mixed sequences can be prepared. It was demonstrated that the orientation switching of pyrimidine-purine mixed sequence PRNAs. In this and preceding studies, we have proposed a new methodology and effective tools for controlling DNA/RNA recognition through the use of an external agent. This-strategy employs novel nucleic acid analogues, i.e. □-peptide ribonucleic acids (^-PRNAs), as the recognition moiety which has a built-in switch triggered by an external factor. In the cases of not only homo-pyrimidine PRNAs but also pyrimidine-purine mixed sequenced PRNAs, the formation of a borate ester of the ribose's cis-2',3'-diol and the simultaneous hydrogen-bonding interaction between the 5'-amide proton and the 2-carbonyl oxygen act as the external and internal switching devices. The results obtained in these studies are encouraging, demonstrating that ^-PRNA form stable hybrid complexes with the complementary oligonucleotides, which are readily dissociated upon addition of borax or boric acid. Moreover, it was investigated that the chirality effect of peptide backbone upon the structure and DNA recognition behavior of PRNA. The orientation of PRNA monomers and oligomers tethered to L-and D-0-glutamic acid backbone could readily be switched from anti to syn by adding borax as an external controlling factor. The cooperative orientation switching and borate formation were enhanced by oligomerization. Furthermore, D-, L-PRNA oligomers were induced different higher-order structure each other. Certainly, D-, L-PRNA were determined right-handed and left-handed coiled structure respectively. The complex of right-handed coiled D-PRNA with complementary DNA was more stable than that of L-PRNA with DNA to indicate that the complexation, which was formed between same right-handed coiled structures of D-PRNA and DNA, was preferable. Then, the on-off switching of DNA recognition with pyrimidine-purine mixed sequence PRNA was demonstrated. PRNA with mixed sequence formed more stable complex with complementary DNA than natural DNA. Moreover, it was revealed that the on-off switching of the DNA recognition of PRNA could be materialized by the synergistic puckering change through borate formation of 2',3'-diol and base orientation switching from anti to syn through the hydrogen bonding formation between 5'-amide proton and carbonyl oxygen at 2 position of pyrimidine nucleoside. Furthermore, nucleic acid models were improved the recognition selectivity as well as its recognition ability. PRNA formed a more stable complex with complementary DNA and binding of PRNA with complementary DNA was sequence specific.This study was the first work for reversible nucleic acid recognition in the rage of physiological condition. These results will demonstrate a strategy for designing the antisense molecule for the next generation, which reacts by environmental stimulation in cell and/or nucleus. Less
期刊论文(134)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1039/b202699f
发表时间: 2002-01-01
期刊: CHEMICAL COMMUNICATIONS
影响因子: 4.9
作者: [Kaneda, M, Asaoka, S, Inoue, Y]
通讯作者: Inoue, Y
H.Sato, Y.Hashimoto, M.Kikkawa, T.Wada, Y.Inoue: "DNA Recognition Control of γ-PRNA and Mismatched Base Effects upon Complex Stability"Nucleic Acids Res. Supple. 2. 159 (2002)
H.Sato、Y.Hashimoto、M.Kikkawa、T.Wada、Y.Inoue:“γ-PRNA 的 DNA 识别控制和错配碱基对复杂稳定性的影响”《核酸研究》2. 159 (2002)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
S.Shim, K.Chul, S.Dong, D.Yoo, T.Wada, Y.Inoue: "Diastereoselectivity Control in Photosensitized Addition of Methanol to (R)-(+)-Limonene"J. Org. Chem. 67. 5718 (2002)
S.Shim、K.Chul、S.Dong、D.Yoo、T.Wada、Y.Inoue:“甲醇光敏加成(R)-( )-柠檬烯中的非对映选择性控制”J。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T.Wada, Y.Liu, B.Li, Y.Inoue: "Complexation Thermodynamics of p-tert-Butylcalix[4]arene Derivatives with Light Lanthanoid Nitrates in Acetonitrile"Supramol.Chem.. 12. 529 (2001)
T.Wada、Y.Liu、B.Li、Y.Inoue:“对叔丁基杯[4]芳烃衍生物与轻质镧系元素硝酸盐在乙腈中的络合热力学”Supramol.Chem.. 12. 529 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
62
    Development of high-sensitivity time-resolved CD measuring system for elucidation of functional biopolymers dynamics
    • 批准号:
      21K18992
    • 项目类别:
      Grant-in-Aid for Challenging Research (Exploratory)
    • 资助金额:
      $4.16万
    • 财政年份:
      2021
    • 负责人:
      WADA Takehiko
    • 依托单位:
    Development of novel therapies for diabetic nephropathy based on the maintenance of differentiation in podocytes
    • 批准号:
      18K08254
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2018
    • 负责人:
      WADA Takehiko
    • 依托单位:
    Mechanisms of maintenance of podocyte cytoskeletal structure against metabolic stress associated with diabetes and Development of novel therapeutic strategies
    • 批准号:
      15K09247
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2015
    • 负责人:
      WADA Takehiko
    • 依托单位:
    Supramolecular Enantiodifferentiating Photocyclodimerization of 2-Anthracenecarboxylate with Proteins and Protein-Polymer Hybrids as Chiral Reaction Medias
    • 批准号:
      24245044
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $29.45万
    • 财政年份:
      2012
    • 负责人:
      WADA Takehiko
    • 依托单位:
    国内基金
    海外基金
    免标记CRISPR-RNA适配体与门逻辑分子诊断新方法研究
    • 批准号:
      2026JJ50010
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      应站明
    • 依托单位:
    RNA m6A修饰通过调控FDX1介导的铜死亡参与补阳还五汤抗脑缺血再灌注损伤作用机制的研究
    • 批准号:
      2026JJ81091
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      刘亮
    • 依托单位:
    基于合成生物标志物的超多重RNA数字化检测平台用于肿瘤精准诊断和分期评估
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      程子译
    • 依托单位:
    RNA 结合蛋白HuR与VEGF-D联合调控舌鳞癌侵袭及转移机制的研究
    • 批准号:
      2026JJ80684
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      龚攀
    • 依托单位: